Skip to content

Patient Journey in Palliative Care Within the NOVO Hospital Group.

A Descriptive and Analytical Study of Patients Who Died in 2024 While Receiving Palliative Care at NOVO Hospital: Patient Characteristics and Implications for General Practice?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07505706
Acronym
NOVOPAL
Enrollment
286
Registered
2026-04-01
Start date
2026-01-05
Completion date
2026-03-31
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End of Life Care, Palliative Care, Terminal Care

Keywords

Palliative Care, End of Life Care, Primary Health Care, General Practitioners, Care Coordination, Place of Death, Advance Directives, Health Services Utilization, Retrospective Studies

Brief summary

This retrospective descriptive study aims to describe the sociodemographic, clinical, and organizational characteristics of patients identified as receiving palliative care who died in 2024 within the NOVO Hospital network. Data from medical records will include patient characteristics, involvement of general practitioners, use of palliative care services, healthcare utilization, and conditions of death. The study hypothesizes that improved characterization of these patients and their care trajectories will help identify opportunities for earlier palliative care referral and better coordination between hospital and community care.

Detailed description

Population aging and the increasing prevalence of chronic diseases and frailty have led to a growing demand for palliative care. End-of-life trajectories are frequently complex and involve multiple transitions between hospital care, home, and long-term care facilities. In many healthcare systems, a large proportion of healthcare expenditures in the last months of life is related to hospitalizations. A better understanding of the characteristics and care pathways of patients receiving palliative care is therefore essential to improve the organization and coordination of end-of-life care. In France, general practitioners play a key role in the follow-up of patients and in coordinating care between hospital and community settings. However, the identification of palliative care needs and the timing of referral to specialized palliative care services remain heterogeneous. Improved knowledge of patient profiles and care trajectories may help identify opportunities to strengthen collaboration between hospital teams and primary care physicians. This retrospective monocentric descriptive study will analyze patients identified as receiving palliative care who died in 2024 within the NOVO Hospital network. Data will be extracted from the medical record system and anonymized prior to analysis. Collected variables will include sociodemographic characteristics, clinical information such as comorbidities, level of autonomy, and data related to the organization of care. Particular attention will be given to the involvement of general practitioners, the use of specialized palliative care teams, and access to home-based care services. The study will also examine healthcare utilization in the last months of life, including hospital admissions and emergency department visits, as well as end-of-life conditions such as the place of death, the presence of advance directives, and the use of continuous deep sedation. By describing patient profiles and care trajectories, this study aims to identify potential factors associated with healthcare utilization and to highlight opportunities to improve early palliative care identification and coordination between hospital and community care.

Interventions

None listed

Sponsors

Hôpital NOVO
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who died between January 1, 2024, and December 31, 2024, in the hospital or in their personal living space (home, nursing home...) * Having "palliative care" status in their medical record * Receiving care at one of the six NOVO hospital sites (Pontoise, Magny-en-Vexin, Beaumont-sur-Oise, Marines, Saint-Martin-du-Tertre, Aincourt) * Whether or not they were followed by a mobile palliative care team

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Number and profiles of patients identified as receiving palliative care who died in 2024 within the NOVO Hospital networkThrough study completion, an average of 3 monthsDescription of the sociodemographic, clinical, and organizational characteristics of patients identified as receiving palliative care, including age, sex, living situation, level of autonomy, primary disease, comorbidities, presence of advance directives, and existence of a documented care plan.

Secondary

MeasureTime frameDescription
Place of death and concordance with patient preferencesThrough study completion, an average of 3 monthsAssessment of the actual place of death (hospital, home, nursing home or other setting) and comparison with the place of death expressed in advance directives or documented care plans when available
Involvement of general practitioners in palliative care managementThrough study completion, an average of 3 monthsEvaluation of the presence of a primary care physician and their involvement in the patient's palliative care pathway, including participation in care planning and coordination with hospital teams
Healthcare utilization in the last months of lifeAt the end of the study, an average of 3 monthsNumber of hospital admissions and emergency department visits during the last six months of life
Timing of referral to palliative careThrough study completion, an average of 3 monthsTime interval between the identification of a palliative situation and the first contact with palliative care services.
Explore ways to improve the early identification of palliative care needs and ensure continuity of care between home and hospitalThrough study completion, an average of 3 monthsTime between the date of death and the start of palliative care

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMathilde BRUN, Doctor

NOVO

PRINCIPAL_INVESTIGATORThomas AKPAN, Doctor

NOVO

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026